Some patients may experience longer-lasting results with certain products, depending on metabolism, dosage, and treatment area
To catch up with the rapid development in the immune metabolism field, this review summarized recent studies on the potential roles of different amino acids and their transporters in the regulation of DCs biology to offer new insights for immune-dysregulated diseases and explore new therapeutic targets
Studies suggest Ipamorelin may reduce hepatic urea synthesis during catabolic states, potentially normalizing nitrogen distribution across tissues
Starting at therapeutic doses immediately often leads to poor tolerance and treatment discontinuation
By doing so, it can significantly reduce hunger, which helps in controlling calorie intake and managing weight effectively
Editing by Michele Gershberg and Bill Berkrot)